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Saudi ArabiaAbstract Objective: To explore the characteristics of medication use and challenges experienced
by the blind patients.
Methods: This cross-sectional descriptive study included blind persons living in Saudi Arabia
who were at least 18 years of age. Participants were recruited through a number of nongovernmen-
tal blind associations (in the central, western, eastern regions), universities, social networks, and
specialized websites for the blind. A questionnaire was designed and administered via face-to-face
meetings with participants and made available online through Google Docs.
Results: There were a total of 121 respondents of which 26 were excluded based on their ability
to visually identify their medications or being <18 years old. The majority of the respondents were
18–29 years old (68%), 49% were male and 51% were female. Around 57% had a college degree
while 27% had a high school degree. Diagnosis with a chronic disease was reported by 71 partici-
pants (79%, 5 missing). The most common diseases were diabetes and asthma (22%) followed by
hypertension (17%). Most blind patients (75%) believed that physicians were the most reliable
source of medication information. The medication information and services provided by pharma-
cists were viewed as inadequate by 46%. The most common challenges encountered by blind
patients were linked to drug identiﬁcation (75%), dose recognition (82%), and identiﬁcation of
expiration date (92%). A large number of patients had to rely on persons with normal vision for
dispensing and administering the medications.
Medication use by blind patients 103Conclusions: Pharmacists can no longer ignore the medication use problems encountered by the
blind people. This study may serve as an initial step for planning improvements in pharmaceutical
services provided to blind patients. The government, pharmaceutical companies and pharmacists
must work in collaboration to address the special needs of the blind.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
In 2010, the World Health Organization (WHO) estimated the
number of visually impaired people to be 285 million, of whom
39 million are blind. The leading causes of blindness world-
wide include cataract, glaucoma and age-related macular
degeneration. About 90% of people who have impaired vision
live in developing countries. In the Eastern-Mediterranean
Region, the WHO estimates that 5 million people (about
13% of the total population) are blind (Pascolini and
Mariotti, 2012). The prevalence of blindness in Saudi Arabia
was based on an old 1980s community based survey that
revealed that 1.5% of the population were blind. That study
also found that the most common cause of blindness in Saudi
Arabia was cataract (Tabbara, 2001). A more recent study that
included adult population attending primary health care cen-
ters in Aljouf province showed that the prevalence of blindness
according to the WHO criteria was 0.8% (Al-Shaaln et al.,
2011).
Visually impaired people have health information needs
that when successfully addressed should result in improvement
in disease management and quality of life. Few studies have
examined the unique needs of this population. Receiving writ-
ten information in inaccessible formats, difﬁculties in commu-
nicating with practitioners, and need for assistance with getting
around healthcare facilities have been reported as concerns by
visually impaired people (Beverley et al., 2004; Cupples et al.,
2012; Sharts-Hopko et al., 2010).
Studies focusing on medication utilization by blind people
are also limited. Published studies involved visually impaired
persons in general and mainly explored the numbers and types
of medications used or focused on difﬁculties using particular
drugs (e.g. glaucoma medications) (Castro et al., 2010; Sleath
et al., 2009). Reading medication labels, administering eye
drops, and measuring liquid doses are some of the difﬁculties
that have been reported. A recent study in Bangkok provided
more insight on medication use problems encountered by blind
patients as well as their coping with these problems. The study
identiﬁed problems with identifying medications and doses,
taking medications at the right time and recognizing expired
medications (Riewpaiboon, 2009).
To the best of our knowledge, no published studies on the
use of medications by blind Saudi patients have been reported
in the literature. Because such data are the cornerstone for
planning improvements in pharmaceutical services provided
to this group of patients, this study was designed to explore
the characteristics of medication use and challenges experi-
enced by the blind patients. The speciﬁc objectives of the study
are to describe how blind patients receive and use their medi-
cations, identify types of pharmaceutical services that are cur-
rently provided, and ﬁnally discover some of the encountered
medication use challenges and relate them to possible
solutions.2. Methods
2.1. Study design
Cross-sectional descriptive study.
2.2. Participants
This study included blind persons living in Saudi Arabia who
were at least 18 years of age. Participants were recruited
through a number of non governmental blind associations
(in the central, western, eastern regions), universities, social
networks, and specialized websites for the blind (online forums
directed toward providing services to blind people). The sam-
ple was selected based on the convenience of sampling over a
period of ﬁve weeks. Persons were excluded if they were visu-
ally able to identify their medication characteristics.
2.3. Data collection
A questionnaire was designed based on data from the litera-
ture review. It consisted of 5 sections: demographic data, med-
ical status, medication use characteristics, source of medication
information, and difﬁculties with medication use. The survey
was piloted for timing and ambiguities and adjustments were
made as necessary.
When logistically feasible, the researches administered the
survey via face-to-face meetings with participants. In addition,
the survey was made available online through Google Docs
and the link to the survey was sent to the participating blind
associations and publicized on social networks and websites.
2.4. Analysis
Descriptive statistics were used to report results.
3. Results
There were a total of 121 respondents of which 26 were
excluded based on their ability to visually identify their medi-
cations or being <18 years old. Table 1 shows the demo-
graphic data of the 95 people included in the study. The
majority of the respondents were 18–29 years old (68%),
49% were male and 51% were female. Around 57% had a col-
lege degree while 27% had a high school degree. Only 33% of
participants reported having a job. Most participants (49%)
were diagnosed with blindness at birth and 91% were able to
read the Braille alphabet. Diagnosis with a chronic disease
was reported by 71 participants (79%, 5 missing). The most
common diseases were diabetes and asthma (22%) followed
by hypertension (17%). Around half of the subjects (54%)
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Figure 2 Sources of medication information.
Table 1 Demographic data (N= 95).
Characteristic Number (%)
Gender
Male 47 (49%)
Female 48 (51%)
Age
18–29 65 (68%)
30–39 21 (22%)
40–49 3 (3%)
50–59 2 (2%)
60–69 0 (0%)
P70 4 (4%)
Education
Elementary school 5 (5%)
Intermediate school 6 (6%)
Secondary school 26 (27%)
College graduate 54 (57%)
Post graduate 4 (4%)
Job Status
Working 31 (33%)
Not Working 64 (67%)
Duration of blindness
Since birth 47 (49%)
61 year 6 (6%)
1–5 years 10 (11%)
5–10 years 10 (11%)
P10 years 22 (23%)
Ability to read Braille alphabet
Yes 86 (91%)
No 9 (9%)
Note: Percentages may not total 100% due to rounding.
104 B.Y. Kentab et al.reported using their medication by themselves while 46%
depended on others. Medication use instructions were received
either by the subjects themselves or through relatives/friends
(48% and 52% respectively, N= 93).
Fig. 1 shows blindness-speciﬁc services provided to the sub-
jects when dispensing their medications. Drug pamphlets in
Braille alphabet were not offered to any of the respondents,
touchable-differentiating mark on the package or label was
offered to 15 respondents, drug instructions in audio format
to 2 respondents, drug labels in Braille alphabet to 17 respon-
dents, and blindness-speciﬁc assistive devices to one respon-
dent. Forty-four of 95 participants (46%) did not think that
medication information and services provided by the pharma-
cist are enough to help them take their medication in the
proper way.io 
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Table 2 Challenges with medication use and coping with
them (N= 95).
Challenges Frequency
(number, %)
With drug identiﬁcation
Yes 71 (75%)
Assisted by persons with normal vision 53 (56%)
Putting touchable-diﬀerentiating mark on
package
12 (13%)
Keeping diﬀerent drugs in diﬀerent places 6 (6%)
No 19 (20%)
Depending on memory 17 (18%)
Have only one medication 2 (2%)
Others* 5 (5%)
With dose recognition
Yes 78 (82%)
Assisted by persons with normal vision 76 (80%)
Putting touchable-diﬀerentiating mark on
package
2 (2%)
No 17 (18%)
Depending on memory 17 (18%)
With remembering administration times
Yes 39 (41%)
Assisted by persons with normal vision 36 (38%)
Guessing 3 (3%)
No 53 (56%)
Depending on memory 53 (56%)
Others* 3 (3%)
With expiration date identiﬁcation
Yes 87 (92%)
Assisted by persons with normal vision 85 (90%)
Guessing 2 (2%)
No 8 (8%)
Depending on memory 8 (8%)
Note: Percentages are rounded.
* Participants did not respond with yes/no but mentioned coping
methods they use.
Table 4 Solutions to improve medication use (N= 95).
Solution Number (%)
Extra explanation by pharmacist
during drug dispensing
38 (40%)
Braille alphabet labeling 86 (91%)
Touchable-diﬀerentiating mark
on drug package
59 (62%)
Drug use information pamphlets
in Braille alphabet
77 (81%)
Telephone helpline 34 (36%)
Availability of information in
an audio format
40 (42%)
Other 5 (5%)
Note: Multiple answers from some respondents.
Medication use by blind patients 105Fig. 2 shows the common sources of medication informa-
tion used by blind patients. When asked which of the men-
tioned medication information sources they thought were the
most reliable, 75% selected the physician while only 21%
selected the pharmacist.
When asked to freely express any medication use problems,
measuring doses of liquid medications was commonly
reported. Table 2 presents the common difﬁculties faced by
the blind when using their medications and how do they cope
with them. The majority of respondents had problems with
drug and expiration date identiﬁcation.Table 3 Effect of blindness on the ability to take medications.
Eﬀect of blindness N Frequency (N
Never
I take the wrong medication 63 15 (24%)
I take a wrong dose of the medication 64 16 (25%)
I take the medication at the wrong time 61 22 (36%)
I take an expired medication 60 28 (47%)
I forget to take the medication 61 12 (20%)
Note: Percentages may not total 100% due to rounding.As shown in Table 3 31% of respondents indicated that
they sometimes take the wrong dose of the medication and
28% indicated that they sometimes take the wrong medication.
Table 4 presents solutions to the medication use challenges
encountered by the blind. Most subjects (91%) reported that
using Braille alphabet labeling will be helpful in improving
their medication use.
4. Discussion
To be useful, healthcare information about medical condi-
tions, treatments, medications and the expected outcomes
should not be only tailored to the requirements of the visually
impaired, but also delivered in a format that is accessible to
them (Beverley et al., 2004).
The ﬁndings in the present study show that the majority of
blind patients (91%) are able to use the Braille alphabet but
unfortunately only 17 patients (18%) had received drug labels
in Braille alphabet and none of them had received medication
information pamphlets in Braille. In addition, about half of
the respondents did not receive medication instructions
directly from pharmacists but had to depend on others for dis-
pensing, receiving instructions and administering medications.
This may create problems with miscommunication, which
combined with problems of identifying medications and doses
particularly of liquid medications, may lead to serious medica-
tion errors.
Comparing our study ﬁndings with those reported by
Riewpaiboon (2009), it appears that Saudi and Thai blind
patients are facing similar difﬁculties with medication use.
Both required additional services to improve their medication
use including extra explanation by pharmacists, touchable-
differentiating mark on label and package, and availabilityumber, %)
Rarely Sometimes Often Always
14 (22%) 27 (43%) 4 (6%) 3 (5%)
14 (22%) 29 (45%) 4 (6%) 1 (2%)
17 (28%) 15 (25%) 2 (3%) 5 (8%)
15 (25%) 12 (20%) 4 (7%) 1 (2%)
11 (18%) 20 (33%) 11 (18%) 7 (11%)
106 B.Y. Kentab et al.of information in audio format. The majority of blind Saudi
patients (91% vs. 77% of Thai patients) indicated that Braille
labeling will help them use their medication in a better way.
In the United States, recognizing the need for making
essential medication information accessible for individuals
with vision loss has lead to the development of the ‘‘Guidelines
for Prescription Labeling and Consumer Medication Informa-
tion for People with Vision Loss’’ (American Society of
Consultant Pharmacists Foundation and American
Foundation for the Blind, Accessed Dec 8, 2012). Although
some of the guideline’s recommendations require specialized
devices that may not be easily available (e.g. audible labels),
others are simple, straightforward and can be readily adopted
by pharmacists. Pharmacists can provide rubber bands and
tactile labels, which can be made using raised dots or strips
of tape, to help patients differentiate medication containers
as well as identify dosing instructions.
Few pharmaceutical companies are including the medica-
tion name in Braille on the drug package. The government’s
regulatory authorities may consider offering incentives to
encourage more companies to offer medication labeling and
pamphlets in Braille. In the meantime, some of the blind
associations are providing Braille ‘‘translations’’ which may
be utilized by pharmacists to develop customized pamphlets
at least for the commonly dispensed medications at their
practice sites.
Although 53% of the respondents used pharmacists as a
source of medication information, only 21% identiﬁed phar-
macists as the most reliable source. It may not be possible to
directly compare this ﬁnding to previous literature reports
given the rarity of studies investigating medication use by blind
patients. However, we can view this result in the light of a
Finnish study (Na¨rhi, 2007) that investigated sources of med-
ication information and their reliability as reported by general
consumers. The study showed that 60% of the consumers uti-
lized pharmacists as source of information. This is relatively
similar to the 53% reported in our study. On the other hand,
the 15–34 year old Finnish respondents, which are similar in
age to the majority of our study participants, regarded phar-
macists as the most reliable source of information. Pharmacists
were rated reliable by 99% of these respondents compared to
97% and 98% who rated doctors and patient information leaf-
lets respectively as reliable. In our study, the low percentage of
blind patients believing in pharmacists being the most reliable
source of medication information coupled with the limited
level of pharmaceutical services provided may indicate a gen-
eral lack of pharmacists’ awareness of the special needs of
the blind patients. Pharmacists in Saudi Arabia have much
to improve in terms of blindness-speciﬁc pharmaceutical ser-
vices and information.
A number of limitations should be kept in mind when inter-
preting the current study ﬁndings. A convenience sample was
used rather than a random sample. In addition, the majority
of the participants were young and may not reﬂect additional
problems faced by elderly patients. Although researchers did
not attempt to offer additional explanations, quality of data
from face-to-face versus online administration of the survey
may be different. Finally, in the absence of recent population
based data on the prevalence of blindness in Saudi Arabia,
the study sample may not represent the medication use issues
faced by all blind patients.Future research may focus on covering a larger representa-
tive sample and discovering if pharmaceutical care needs are
different among subsets of blind patients (e.g. young versus
elderly). The classes of both prescription/nonprescription med-
ications that are commonly used by blind patients and the efﬁ-
cacy of some of the solutions presented in this study are also
worth investigating.
5. Conclusion
Pharmacists can no longer ignore the medication use problems
encountered by the blind people. This study may serve as an
initial step for planning improvements in pharmaceutical ser-
vices provided to blind patients. The government, pharmaceu-
tical companies and pharmacists must work in collaboration to
address the special needs of the blind.
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